Concepedia
Statistics
Publications
2
Citations
29
H-Index
Active since
2021
Affiliations
Principia Biopharma (United States)(Current)
Katherine A. Chu is an author at Principia Biopharma (United States).
Publications per year
2021–2023
Preclinical Mechanisms of Topical PRN473, a Bruton Tyrosine Kinase Inhibitor, in Immune-Mediated Skin Disease Models
Yan Xing, Katherine A. Chu, Jyoti Wadhwa et al. · ImmunoHorizons · 2021 · 17 citations · Full text
Rilzabrutinib, a reversible covalent Bruton's tyrosine kinase inhibitor: Absorption, metabolism, excretion, and absolute bioavailability in healthy participants
Sibel Ucpinar, Patrick F. Smith, Long Li et al. · Clinical and Translational Science · 2023 · 12 citations · Full text
1–2 of 2